Other Medicines Law & Policy resources
In addition to our research and blogs, Medicines Law & Policy has also been active in responding to the Covid-19 pandemic (and is an active participant in ongoing processes to better prepare for the next one. Additionally, we create tools for countries and others looking to increase access to medicines through use of flexibilities in the international intellectual property system, and maintain a database of useful links and other helpful sites.
Navigate to our other work below.
OUR RESEARCH
ML&P delves into complex public health issues, seeking to make the legal implications of international legislation clearer, and to make policy recommendations that can improve public health.
THE PANDEMIC ACCORD
ML&P has been closely following the process towards the creation of a new international instrument to better prevent, prepare for and respond to the next pandemic. See our resources from that work here.
COVID-19
The Covid-19 pandemic underlined concerns about access to medicines and vaccines. ML&P experts helped respond with explanations, policy options, and legal guidance.
OUR TOOLS
Countries and others looking to increase access to medicines can make use of flexibilities in the international intellectual property system. Medicines Law & Policy has created several tools to make it easier to operationalise these flexibilities.
USEFUL LINKS
Here we gather links to sources outside ML&P that we believe provide helpful information, resources, and relevant data for those working on international intellectual property law and policy and access to medicines.